PROVIDER PROFILE · NPI 1710906532

Manuel Figueroa-GonzalezMD

NephrologySan Juan, PRI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

117

Unique beneficiaries

—

Total services

368

Distinct HCPCS

Medicare payment

$33K

Peer benchmark

Total Medicare services vs. 104 Nephrology providers in PR — top quintile (cohort median 141).

PRESCRIBING · PART D · 2024

Total Rx claims

2,012

Beneficiaries

—

Total drug cost

$171K

Distinct drugs

Brand share

21.6%

Top prescribed drugs

Sevelamer Carbonate166 claims

Losartan Potassium115 claims

Gabapentin105 claims

Calcium Acetate101 claims

Doxazosin Mesylate87 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$56

Payment records

By payment type

Food and Beverage$56

REFERRAL NETWORK

Where Manuel Figueroa-Gonzalez's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
HOSPITAL ESPANOL AUXILIO MUTUO DE PUERTO RICO, INC.	46	131
Spectra East, Inc. Clinical Laboratory · Rockleigh, NJ	37	189
Jose Nieves-Rivera Nephrology · San Juan, PR	33	161
RENDON, WILFREDO	20	35
BIO-MEDICAL APPLICATIONS OF ARECIBO, INC.	18	151
Carmelo Santana-Lopez Infectious Disease · Hato Rey, PR	16	34
Tomas Jimenez Diagnostic Radiology · San Juan, PR	15	44
Esteban Ramos-Alvarez Internal Medicine · San Juan, PR	11	42

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history